Status
Apply
Histology
Apply
Grade
Apply
Platin
Apply
Prior lines
Apply
Biomarkers
Apply
Remove all filters
Open

222730

Trial drug
GSK5733584
Histology
Serous, Endometrioid
Grade
High grade
Platin
Platinum resistant
Secondary platinum refractory
Prior lines
1, 2, 3, 4
Phase
I
Open

IMGN853-0424

Trial drug
Mirvetuximab Soravtansine
Histology
Serous, Mucinous Endometrioid Clear-cell
Grade
High grade, Low grade, Other / unknown
Platin
Platinum sensitive
Platinum resistant
Secondary platinum refractory
Prior lines
1, 2, 3, 4
Phase
II
Open

DDriver

Trial drug
Tuvusertib, Lartesertib, Niraparib
Histology
Serous, Endometrioid
Grade
High grade
Platin
Platinum sensitive
Prior lines
1, 2
Phase
II
Biomarkers
BRCA1, HRD, BRCA2
Open

BGOG-ov81/VS-6766-301

Trial drug
Avutometinib, Defactinib
Histology
Serous
Grade
Low grade
Platin
Platinum sensitive
Platinum resistant
Secondary platinum refractory
Prior lines
1, 2, 3, 4, >4
Phase
III
Open

REGN5668

Trial drug
REGN5668, REGN4018, Cemiplimab
Histology
Serous, Endometrioid Clear-cell Mucinous Other (bv. mixed/rare)
Grade
High grade, Low grade
Platin
Platinum sensitive
Platinum resistant
Primary platinum refractory
Secondary platinum refractory
Prior lines
1, 2, 3, 4
Phase
1/2
Open

REGN4018

Trial drug
REGN4018, Cemiplimab
Histology
Serous, Endometrioid Clear-cell Mucinous Other (bv. mixed/rare)
Grade
High grade, Low grade
Platin
Platinum sensitive
Platinum resistant
Primary platinum refractory
Secondary platinum refractory
Prior lines
1, 2, 3, 4
Phase
1/2
Open

BGOG-ov80/ALEPRO

Trial drug
Abemaciclib, Letrozole
Histology
Serous, Endometrioid Other (bv. mixed/rare)
Grade
Low grade
Platin
Platinum sensitive
Platinum resistant
Prior lines
1, 2, 3, 4, >4
Phase
II
Open

BGOG-ov76/GLORIOSA

Trial drug
Mirvetuximab soravtansin, Bevacizumab
Histology
Serous
Grade
High grade
Platin
Platinum sensitive
Prior lines
1
Phase
III
Biomarkers
⍺FR
1
2
Remove all filters
Status
Histology
Grade
Platin
Prior lines
Biomarkers
Close
Filter trials